Showing results (21-30 of 442) with videos related to
Sort By:
Pageof 45
Frontiers in Pharmacology|June 1, 2022
Less Timely Initiation of Glucose-Lowering Medication Among Younger and Male Patients With Diabetes and Similar Initiation of Blood Pressure-Lowering Medication Across Age and Sex: Trends Between 2015 and 2020Martina Ambrož, Sieta T de Vries, Klaas Hoogenberg, et al.Journal of Bioethical Inquiry|July 16, 2016
The Ethics of Deprescribing in Older AdultsEmily Reeve, Petra Denig, Sarah N Hilmer, et al.Journal of Clinical Pharmacy and Therapeutics|December 1, 1991
Prescribing pattern in a Dutch university hospitalP Denig, F M Haaijer-Ruskamp, A Versluis, et al.Current Medical Research and Opinion|September 12, 2015
Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patientsF M de Vries, J Voorham, E Hak, et al.Frontiers in Pharmacology|October 11, 2021
Older Age, Polypharmacy, and Low Systolic Blood Pressure Are Associated With More Hypotension-Related Adverse Events in Patients With Type 2 Diabetes Treated With AntihypertensivesMartina Ambrož, Sieta T de Vries, Klaas Hoogenberg, et al.Social Science & Medicine (1982)|April 1, 1993
Towards understanding treatment preferences of hospital physiciansP Denig, F M Haaijer-Ruskamp, H Wesseling, et al.BMC Family Practice|April 23, 2009
Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative studyElisabeth AB, Petra Denig, Ton van Vliet, et al.Pharmacoepidemiology and Drug Safety|October 18, 2011
Development of a minimal set of prescribing quality indicators for diabetes management on a general practice levelLiana Martirosyan, Flora M Haaijer-Ruskamp, Jozé Braspenning, et al.Journal of Internal Medicine|August 1, 1993
Drug expectations and drug choices of hospital physiciansP Denig, F M Haaijer-Ruskamp, H Wesseling, et al.Journal of Clinical Epidemiology|December 12, 2018
A systematic review finds inconsistency in the measures used to estimate adherence and persistence to multiple cardiometabolic medicationsSofa D Alfian, Ivan S Pradipta, Eelko Hak, et al.Pageof 45